Condensed Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	$ (12,188,363)	$ (14,096,278)
Less: Loss from discontinued operations	(3,983,107)	(7,033,406)
Net loss from continuing operations	(8,205,256)	(7,062,872)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	83,854
Amortization of intangible assets	288,700
Stock-based compensation	5,784,305	7,766,096
Issuance of common stock for services	20,000	1,107,502
Change in fair value of financial instruments	14,759	(352,588)
Accrued interest income on notes receivable from third party	(6,133)
Change in earn-out liability	(13,582)
Provision for bad debt	686,641
Changes in operating assets and liabilities:
Accounts receivable	(19,847)
Customer short term notes receivable	(698,103)
Customer long term notes receivable	(952,708)
Deferred revenue	541,907
Prepaid insurance	(2,023)	34,256
Other assets	(30,000)
Accounts payable and accrued liabilities	53,947	(11,854)
Net cash used in operating activities from continuing operations	(2,453,539)	1,480,540
Net cash used in discontinued operations	(4,137,481)	(9,476,271)
Net cash used in operating activities	(6,591,020)	(7,995,731)
Cash flows from investing activities:
Acquisition of Intellectual Capital Management LLC ("SMS")	(1,000,000)
Payment of deferred acquisition payable - intellectual Capital Mgmt, LLC	(380,000)
Capitalized software	(283,080)
Short term notes receivable from third party	(410,000)
Acquisition of TechXpress Web business	(454,641)
Sale of property and equipment	251	2,505
Payment on long term liabilities (SBA Loans)	(226,522)
Purchase of property and equipment	(382,149)
Net cash (used in) provided by investing activities from continuing operations	(3,136,141)	2,505
Net cash used in discontinued operations
Net cash used in investing activities	(3,136,141)	2,505
Cash flows from financing activities:
Net proceeds from issuance of preferred stock, common stock, and warrants	10,472,003
Net proceeds from exercise of warrants to purchase common stock		1,384,972
Proceeds from issuance of convertible debt		500,000
Net cash provided by financing activities from continuing operations	10,472,003	1,884,972
Net cash used in discontinued operations
Net cash used in financing activities	10,472,003	1,884,972
Net increase (decrease) in cash and cash equivalents	744,842	(6,108,254)
Cash and cash equivalents at beginning of the year	497,313	6,605,567
Cash and cash equivalents at end of the year	$ 1,242,155	$ 497,313